Literature DB >> 29480581

Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus.

Ana Gutiérrez-Rodríguez1,2, Itziar Bonilla-Del Río1,2, Nagore Puente1,2, Sonia M Gómez-Urquijo1,2, Christine J Fontaine3, Jon Egaña-Huguet1,2, Izaskun Elezgarai1,2, Sabine Ruehle4, Beat Lutz4, Laurie M Robin5,6, Edgar Soria-Gómez1,2, Luigi Bellocchio5,6, Jalindar D Padwal7, Mario van der Stelt7, Juan Mendizabal-Zubiaga1,2, Leire Reguero1,2, Almudena Ramos1,2, Inmaculada Gerrikagoitia1,2, Giovanni Marsicano5,6, Pedro Grandes1,2,3.   

Abstract

Astroglial type-1 cannabinoid (CB1 ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre- and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB1 receptors. In particular, brain CB1 receptors are mostly localized at cells' plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB1 receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB1 receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB1 -KO mice) and also generated genetic rescue mice to re-express CB1 receptors exclusively in astrocytes (GFAP-CB1 -RS). To better identify astroglial structures by immunoelectron microscopy, global CB1 knock-out (CB1 -KO) mice and wild-type (CB1 -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB1 -KO and -WT mice, respectively. Furthermore, double immunogold (for CB1 ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB1 receptors are present in astroglial mitochondria from different hippocampal regions of CB1 -WT, GFAP-CB1 -RS and GFAPhrGFP-CB1 -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB1 receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB1 receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cannabinoids; glia; immunoelectron microscopy; intracellular receptors; mitochondria; tripartite synapse

Mesh:

Substances:

Year:  2018        PMID: 29480581     DOI: 10.1002/glia.23314

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  23 in total

1.  Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Authors:  Mary K Swinton; Aliyah Carson; Francesca Telese; Ana B Sanchez; Benchawanna Soontornniyomkij; Leila Rad; Isabella Batki; Brandi Quintanilla; Josué Pérez-Santiago; Cristian L Achim; Scott Letendre; Ronald J Ellis; Igor Grant; Anne N Murphy; Jerel Adam Fields
Journal:  Neurobiol Dis       Date:  2019-06-22       Impact factor: 5.996

2.  How lactate links cannabis to social behaviour.

Authors:  Pierre J Magistretti
Journal:  Nature       Date:  2020-07       Impact factor: 49.962

Review 3.  New Insights in Cannabinoid Receptor Structure and Signaling.

Authors:  Lingyan Ye; Zheng Cao; Weiwei Wang; Naiming Zhou
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

4.  Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice.

Authors:  Brian R Christie; Pedro Grandes; Sara Peñasco; Irantzu Rico-Barrio; Nagore Puente; Christine J Fontaine; Almudena Ramos; Leire Reguero; Inmaculada Gerrikagoitia; Fernando Rodríguez de Fonseca; Juan Suarez; Sergio Barrondo; Xabier Aretxabala; Gontzal García Del Caño; Joan Sallés; Izaskun Elezgarai; Patrick C Nahirney
Journal:  Neuropsychopharmacology       Date:  2019-09-30       Impact factor: 7.853

5.  Glucose metabolism links astroglial mitochondria to cannabinoid effects.

Authors:  Daniel Jimenez-Blasco; Arnau Busquets-Garcia; Etienne Hebert-Chatelain; Roman Serrat; Carlos Vicente-Gutierrez; Christina Ioannidou; Paula Gómez-Sotres; Irene Lopez-Fabuel; Monica Resch-Beusher; Eva Resel; Dorian Arnouil; Dave Saraswat; Marjorie Varilh; Astrid Cannich; Francisca Julio-Kalajzic; Itziar Bonilla-Del Río; Angeles Almeida; Nagore Puente; Svein Achicallende; Maria-Luz Lopez-Rodriguez; Charlotte Jollé; Nicole Déglon; Luc Pellerin; Charlène Josephine; Gilles Bonvento; Aude Panatier; Beat Lutz; Pier-Vincenzo Piazza; Manuel Guzmán; Luigi Bellocchio; Anne-Karine Bouzier-Sore; Pedro Grandes; Juan P Bolaños; Giovanni Marsicano
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

6.  Mitochondrial Localization of CB1 in Progesterone-producing Cells of Ovarian Interstitial Glands of Adult Mice.

Authors:  Anussara Kamnate; Juthathip Sirisin; Masahiko Watanabe; Hisatake Kondo; Wiphawi Hipkaeo; Surang Chomphoo
Journal:  J Histochem Cytochem       Date:  2021-12-17       Impact factor: 2.479

7.  Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner.

Authors:  Julia De Meij; Zain Alfanek; Lydie Morel; Fanny Decoeur; Quentin Leyrolle; Katherine Picard; Micael Carrier; Agnes Aubert; Alexandra Séré; Céline Lucas; Gerald Laforest; Jean-Christophe Helbling; Marie-Eve Tremblay; Daniela Cota; Marie-Pierre Moisan; Giovanni Marsicano; Sophie Layé; Agnès Nadjar
Journal:  Cannabis Cannabinoid Res       Date:  2021-09-29

Review 8.  Melatonin and cannabinoids: mitochondrial-targeted molecules that may reduce inflammaging in neurodegenerative diseases.

Authors:  Sebastián García; Virna Margarita Martín Giménez; Feres José Mocayar Marón; Russel J Reiter; Walter Manucha
Journal:  Histol Histopathol       Date:  2020-03-10       Impact factor: 2.303

9.  Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease.

Authors:  Eva Martínez-Pinilla; David Aguinaga; Gemma Navarro; Alberto J Rico; Julen Oyarzábal; Juan A Sánchez-Arias; José Luis Lanciego; Rafael Franco
Journal:  Mol Neurobiol       Date:  2019-01-28       Impact factor: 5.590

10.  High-resolution Immunoelectron Microscopy Techniques for Revealing Distinct Subcellular Type 1 Cannabinoid Receptor Domains in Brain.

Authors:  Nagore Puente; Itziar Bonilla-Del Río; Svein Achicallende; Patrick C Nahirney; Pedro Grandes
Journal:  Bio Protoc       Date:  2019-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.